(Total Views: 503)
Posted On: 09/08/2021 5:20:35 PM
Post# of 145874
Whether a combination with checkpoint inhibitors or other drugs is worthwhile depends on whether leronlimab already takes care of the problem. For example - leronlimab downregulates PD-L1, to what extent is unknown, if it downregulates sufficiently then a PD-1/PD-L1 inhibitor would add nothing.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)